DND1 Antibody (monoclonal) (M07)
Mouse monoclonal antibody raised against a full length recombinant DND1.
|Reactivity||Human, Mouse, Rat|
|Other Names||Dead end protein homolog 1, RNA-binding motif, single-stranded-interacting protein 4, DND1, RBMS4|
|Target/Specificity||DND1 (NP_919225, 167 a.a. ~ 260 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||DND1 Antibody (monoclonal) (M07) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Screening for germline DND1 mutations in testicular cancer patients. Sijmons RH, et al. Fam Cancer, 2010 Sep. PMID 20411342.RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Kedde M, et al. Cell, 2007 Dec 28. PMID 18155131.Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Linger R, et al. Genes Chromosomes Cancer, 2008 Mar. PMID 18069663.The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Youngren KK, et al. Nature, 2005 May 19. PMID 15902260.The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Gerhard DS, et al. Genome Res, 2004 Oct. PMID 15489334.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.